Subcutaneous alemtuzumab may be useful in the treatment of steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Gomez-Almaguer, David [1 ]
Ruiz-Arguelles, Guillermo J. [2 ]
Gonzalez-Llano, Oscar [1 ]
Guttierez-Aguire, Homero C. [1 ]
Cantu-Rodriguez, Olga G. [1 ]
Jaime-Perez, Jose C. [1 ]
Giralt, Sergio [3 ]
机构：
[1] Hosp Univ, Monterrey, Mexico
[2] Ctr Hematol & Med Interna Puebla, Puebla, Mexico
[3] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2983.2983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2983
引用
收藏
页码：876A / 876A
页数：1
相关论文
共 50 条
  • [41] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Diseas
    Toama, Wael
    Fiala, Mark A.
    Pusic, Iskra
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [42] How I treat steroid-refractory acute graft-versus-host disease
    Martin, Paul J.
    BLOOD, 2020, 135 (19) : 1630 - 1638
  • [43] Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
    Rashidi, Armin
    DeFor, Todd E.
    Holtan, Shernan G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2297 - 2302
  • [44] FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Przepiorka, Donna
    Luo, Lola
    Subramaniam, Sriram
    Qiu, Junshan
    Gudi, Ramadevi
    Cunningham, Lea C.
    Nie, Lei
    Leong, Ruby
    Ma, Lian
    Sheth, Christopher
    Deisseroth, Albert
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Pazdur, Richard
    ONCOLOGIST, 2020, 25 (02): : E328 - E334
  • [45] Role of Extracorporeal Photopheresis (ECP) in Treatment of Steroid-Refractory Acute Graft-versus-Host Disease
    Greinix, Hildegard T.
    Worel, Nina
    Knobler, Robert
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (12) : 1747 - 1748
  • [46] TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE WITH BASILIXIMAB AND ETANERCEPT IN EARLY PERIOD
    Tan, Y.
    Luo, Y.
    Shi, J.
    He, J.
    Zhao, Y.
    Lai, X.
    Zheng, W.
    Sun, J.
    Zheng, Y.
    Cai, Z.
    Lin, M.
    Huang, H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S337 - S337
  • [47] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
    Moiseev, Ivan
    Morozova, Elena
    Barabanshikova, Maria
    Kozlov, Andrey
    Rudakova, Tatyana
    Klimova, Olesya
    Tcvetkov, Nikolai
    Pirogova, Olga
    Borzenkova, Evgeniya
    Kozhokar, Polina
    Ekushev, Kirill
    Paina, Olesya
    Bykova, Tatyana
    Darskaya, Elena
    Bondarenko, Sergey
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
  • [48] Rituximab for steroid-refractory chronic graft-versus-host disease
    Cutler, Corey
    Miklos, David
    Kim, Haesook T.
    Treister, Nathaniel
    Woo, Sook-Bin
    Bienfang, Don
    Klickstein, Lloyd B.
    Levin, Jesse
    Miller, Katherine
    Reynolds, Carol
    Macdonell, Rebecca
    Pasek, Mildred
    Lee, Stephanie J.
    Ho, Vincent
    Soiffer, Robert
    Antin, Joseph H.
    Ritz, Jerome
    Alyea, Edwin
    BLOOD, 2006, 108 (02) : 756 - 762
  • [49] Pentostatin in steroid-refractory chronic graft-versus-host disease
    Bolanos-Meade, J
    Jacobsohn, D
    Anders, V
    Higman, M
    Chen, A
    Phelps, M
    Vogelsang, GB
    BLOOD, 2005, 106 (11) : 513A - 514A
  • [50] Successful therapy of steroid-refractory acute graft-versus host disease with sequential alemtuzumab
    Repp, R.
    Claviez, A.
    Schrauder, A.
    Schub, N.
    Gahn, B.
    Gramatzki, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 117 - 117
12345